Can web 2.0 reboot clinical trials?

被引：40

作者：

Allison, Malorye

机构：

[1] Malorye Allison is a freelance writer based in Acton,

[2] MA.,undefined

来源：

NATURE BIOTECHNOLOGY | 2009年 / 27卷 / 10期

关键词：

D O I：

10.1038/nbt1009-895

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 [微生物学]; 090105 [作物生产系统与生态工程];

摘要：

Dozens of companies are trying to leverage social networking and other software tools to accelerate trials and reduce their cost.

引用

页码：895 / 902

页数：8

共 5 条

[1]

ARNST C, 2008, BUSINESS WEEK 1204

[2]

Leucine-rich repeat kinase 2 mutations and Parkinson's disease: three questions [J].

Greggio, Elisa ;

Cookson, Mark R. .

ASN NEURO, 2009, 1 (01) :13-24

[3]

Project Zero Delay: A Process for Accelerating the Activation of Cancer Clinical Trials [J].

Kurzrock, Razelle ;

Pilat, Susan ;

Bartolazzi, Marcel ;

Sanders, Dwana ;

van Wart Hood, Jill ;

Tucker, Stanley D. ;

Webster, Kevin ;

Mallamaci, Michael A. ;

Strand, Steven ;

Babcock, Eileen ;

Bast, Robert C., Jr. .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (26) :4433-4440

[4]

Commentary: Practicing on the Tip of an Information Iceberg? Evidence of Underpublication of Registered Clinical Trials in Oncology [J].

Ramsey, Scott ;

Scoggins, John .

ONCOLOGIST, 2008, 13 (09) :925-929

[5]

WESTING AF, 2007, PUBLIC VIEWS PRIVACY

← 1 →